THCB Spotlight: Warris Bokhari, Claimable

One of the most interesting follows on Linkedin is Warris Bokhari from Claimable. He’s a British MD, who has had stints not only as a doc in the UK, but also as a health tech and health insurance exec in the US. But now he’s at war with the system, in particular working for patients…

Read More

How much does the US spend on health care?

Fiore et al. (2026) just released their annual national health expenditure projections in Health Affairs. I summarize some of the key findings in Q&A format. How much is the US currently spending on health care? $5.7 trillion. This is represents an increase in healthcare spending as a share of GDP from 18.0% in 2024 to…

Read More

A Metabolic Disease Posing Severe Pancreatic Risks Gets Its First FDA-Approved Therapy

Ionis Pharmaceuticals’ Tryngolza is now the first approved therapy for treating severe hypertriglyceridemia, a prevalent chronic metabolic disorder that can lead to acute pancreatitis. This drug is a key piece of Ionis’s pivot away from partnering its assets, and instead developing and commercializing them on its own. The post A Metabolic Disease Posing Severe Pancreatic…

Read More